Trial Profile
A Randomized, Open-label, Single-dose, 2-way Cross-over Study to Compare the Safety and the Pharmacokinetic Characteristics of the Co-administration of Telmisartan and Rosuvastatin and YH16410 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Rosuvastatin/telmisartan (Primary) ; Rosuvastatin; Telmisartan
- Indications Dyslipidaemias; Hypertension
- Focus Pharmacokinetics
- Sponsors Yuhan
- 13 Nov 2013 New trial record